OPYZEP NALOXONE

Serial Number 79206643
Registration 5366955
709

Registration Progress

Application Filed
Dec 12, 2016
Under Examination
Approved for Publication
Oct 17, 2017
Published for Opposition
Oct 17, 2017
Registered
Jan 2, 2018

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: OPYZEP NALOXONE
Previous Owner: CROSSJECT

Trademark Image

OPYZEP NALOXONE

Basic Information

Serial Number
79206643
Registration Number
5366955
Filing Date
December 12, 2016
Registration Date
January 2, 2018
Published for Opposition
October 17, 2017
Cancellation Date
July 19, 2024
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
709
Status Date
Jul 19, 2024

Rights Holder

CROSSJECT

99
Address
60 L Avenue du 14 juillet
F-21300 CHENOVE
FR

Ownership History

CROSSJECT

Original Applicant
99
FR

CROSSJECT

Owner at Publication
99
FR

CROSSJECT

Original Registrant
99
FR

Legal Representation

Attorney
Brooks R. Bruneau

Application History

31 events
Date Code Type Description Documents
Jul 11, 2025 INNT P TOTAL INVALIDATION PROCESSED BY THE IB Loading...
Jun 19, 2025 INTS P TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB Loading...
Jun 18, 2025 INPC P INVALIDATION PROCESSED Loading...
Mar 19, 2025 INTR P TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Loading...
Jul 19, 2024 C71T O CANCELLED SECTION 71 Loading...
Jan 2, 2023 REM3 E COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Loading...
May 25, 2018 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 10, 2018 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 10, 2018 FIMP P FINAL DISPOSITION PROCESSED Loading...
Apr 2, 2018 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jan 2, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 21, 2017 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Oct 17, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 17, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2017 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Oct 4, 2017 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Sep 27, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 14, 2017 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 12, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 12, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 10, 2017 ALIE A ASSIGNED TO LIE Loading...
Aug 29, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 3, 2017 RFNT P REFUSAL PROCESSED BY IB Loading...
May 12, 2017 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
May 12, 2017 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 12, 2017 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 12, 2017 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 11, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 8, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
May 8, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 4, 2017 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Design Mark
The mark consists of in part the wording "OPYZEP" in upper-case stylized font and "NALOXONE" in lower-case stylized font. The letters "OPY" are black and the letters "ZEP" are gray. The word "NALOXONE" is yellow. The mark also includes a design element in the upper right corner comprised of an orange circle. Inside the circle is a red cross outlined in white. A yellow and white leaf appears in the center of the red cross.
Color Claim
The color(s) black, gray, white, red, orange and yellow is/are claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"NALOXONE"